Used in treatment of benign prostatic hypertrophy and pattern hair loss. Reduces risk of prostate cancer.
|
Prototype Med
|
finasteride (Propecia and Proscar)
|
|
Other Meds
|
dutasteride (Avodart)
|
|
Treatment of benign prostatic hypertrophy (also reduces the risk of prostate cancer)
|
|
Treatment of male pattern hair loss (Propecia)
|
|
Reduced libido and ejaculate volume
|
|
Reduced prostate-specific antigen (PSA) levels
|
|
Gynecomastia (males)
|
|
Tell clients about the possibility of reductions in libido and ejaculate volume.
|
|
Obtain a baseline PSA level and monitor periodically.
|
|
Expect PSA levels to decline with therapy.
|
|
Evaluate any increases in PSA level, as they may indicate prostate cancer or nonadherence to therapy.
|
|
Monitor for breast enlargement.
|
|
Evaluate if there is concern for body image.
|
|
Take orally, with or without food.
|
|
Crush the tablets if needed.
|
|
Expect drug therapy to be lifelong.
|
|
Ensure that women do not handle the drug, especially if crushed, due to the possibility of transdermal absorption.
|
|
Expect therapeutic effects to take 6 to 12 months.
|
|
Expect decreases in libido and ejaculate volume.
|
|
Undergo regular prostate cancer screenings.
|
|
Report breast enlargement.
|
|
Pregnancy (teratogenic)
|
|
Female, children
|
|
Liver impairment
|
|
Obstructive uropathy
|
No comments yet.
Cheatography n. The art of mapping complex subjects into clear, instantly navigable reference guides.
